Mustang Bio, Inc. (MBIO)
0.4711
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
Mustang Bio Market Cap : 3.570M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.570M |
| October 01, 2026 | 3.540M |
| September 30, 2026 | 3.508M |
| September 29, 2026 | 3.634M |
| September 28, 2026 | 3.841M |
| September 25, 2026 | 3.943M |
| September 24, 2026 | 3.987M |
| September 23, 2026 | 3.875M |
| September 22, 2026 | 4.024M |
| September 21, 2026 | 4.168M |
| September 18, 2026 | 4.090M |
| September 17, 2026 | 3.713M |
| September 16, 2026 | 3.789M |
| September 15, 2026 | 3.815M |
| September 14, 2026 | 3.865M |
| September 11, 2026 | 3.843M |
| September 10, 2026 | 3.940M |
| September 09, 2026 | 4.002M |
| September 08, 2026 | 4.101M |
| September 04, 2026 | 4.114M |
| September 03, 2026 | 4.243M |
| September 02, 2026 | 4.115M |
| September 01, 2026 | 4.153M |
| August 31, 2026 | 4.073M |
| August 28, 2026 | 4.074M |
| Date | Value |
|---|---|
| August 27, 2026 | 4.168M |
| August 26, 2026 | 4.243M |
| August 25, 2026 | 4.183M |
| August 24, 2026 | 4.178M |
| August 21, 2026 | 4.385M |
| August 20, 2026 | 4.341M |
| August 19, 2026 | 4.350M |
| August 18, 2026 | 4.319M |
| August 17, 2026 | 4.503M |
| August 14, 2026 | 4.497M |
| August 13, 2026 | 4.501M |
| August 12, 2026 | 4.587M |
| August 11, 2026 | 4.607M |
| August 10, 2026 | 4.472M |
| August 07, 2026 | 4.552M |
| August 06, 2026 | 4.359M |
| August 05, 2026 | 4.523M |
| August 04, 2026 | 4.501M |
| August 03, 2026 | 4.369M |
| July 31, 2026 | 4.321M |
| July 30, 2026 | 4.500M |
| July 29, 2026 | 4.395M |
| July 28, 2026 | 4.784M |
| July 27, 2026 | 4.243M |
| July 24, 2026 | 4.259M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
| Biogen, Inc. | 32.48B |
Market Cap Related Metrics
| Price to Book Value | 0.4731 |
| Price | 0.4711 |
| Earnings Yield | -95.48% |